EGFR and breast cancer: Furthermore, our recent observations on inhibition of EGF effect and dissociation of EGFR complex formation with the use of SST in breast cancer cells might serve as a possible mechanism to avert tumour growth resistance and toxicities as proposed in the use of cisplatin [468,469,470].